A recurrence-free survivor with chemotherapy-refractory small cell lung cancer after pneumonectomy: A case report and review of the literature

RATIONALE: The optimal therapeutic regimen for chemotherapy-refractory and node-positive small-cell lung cancer (SCLC) is criticizable for the lack of evidence. PATIENT CONCERNS: A patient with locally advanced SCLC was insensitive to the first-line chemotherapy of etoposide, irinotecan, and cisplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yong, Kong, Feng-Wei, Wang, Heng, Wang, Xiang, Zhang, Hui, Wu, Wen-Bin, Zhang, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709029/
https://www.ncbi.nlm.nih.gov/pubmed/29382030
http://dx.doi.org/10.1097/MD.0000000000008922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5709029/
https://www.ncbi.nlm.nih.gov/pubmed/29382030
http://dx.doi.org/10.1097/MD.0000000000008922

Ejemplares similares